Addiction
Study register · detail Systematische Review + Meta-Analyse · Addiction · 2020

What is the prevalence and risk of cannabis use disorders among people who use cannabis? a systematic review and meta-analysis.

Harm GRADE High 333 citations
Samplek = 21 Studien
DurationStudies published 2009–2020
EndpointPrevalence of cannabis use…
Blindingn.a.
DesignSystematische Review + Meta-Analyse
Key finding

About one fifth of all cannabis users develop a cannabis use disorder, in regularly using adolescents the risk rises to one third.

Summary

SR/MA of 21 studies on prevalence and risk of cannabis use disorders (CUD) among cannabis users: 22% (95% CI 18–26%) met CUD criteria, 13% (10–15%) cannabis dependence (CD). Cohort data show that the risk of developing a CD rises to 33% (22–44%) with regular (weekly/daily) use; increased risk with early onset and frequent use during adolescence.

P
PopulationPersons who use cannabis (general population, cross-sectional and cohort studies), pooled sample from 21 studies
I
InterventionCannabis use (various patterns, including regular/daily use)
O
OutcomePrevalence of a cannabis use disorder (CUD) among cannabis users: 22% (95%-CI 18–26%); cannabis abuse (CA): 13% (95%-CI 8–18%); cannabis dependence (CD): 13% (95%-CI 10–15%); risk for CD with regular use in adolescents: 33% (95%-CI 22–44%)
Confidence in the evidence
High

The highest of four GRADE levels, the effect estimate is very reliable.

Quality profile
Sample size
Blinding
Effect size Harm
Citations / year
Authors
Leung J, Chan GCK, Hides L, Hall WD.
DOI 10.1016/j.addbeh.2020.106479
Design: Systematische Review + Meta-Analyse
Share
Abstract
<h4>Background and aims</h4>We aim to quantify the prevalence and risk of having a cannabis use disorder (CUD), cannabis abuse (CA) or cannabis dependence (CD) among people in the general population who have used cannabis.<h4>Method</h4>We conducted a systematic review of epidemiological cross-sectional and longitudinal studies on the prevalence and risks of CUDs among cannabis users. We identified studies published between 2009 and 2019 through PubMed, the Global Burden Disease (GBD) Database, and supplementary searches up to 2020. The outcomes of interest were CUDs based on DSM or ICD criteria. Estimates were synthesized using random-effects meta-analyses, followed by meta-regression of study characteristics on effect sizes.<h4>Results</h4>From 1383 records identified, 21 studies were included. Meta-analyses showed that among people who used cannabis, 22% (18-26%) have CUD, 13% (8-18%) have CA, and 13% (10-15%) have CD. Estimates from cohort studies, showed that the risk of developing CD increased to 33% (22-44%) among young people who engaged in regular (weekly or daily) use of cannabis. There was a lack of data from cohort studies to estimate the risk of CUD or CA among regular cannabis users.<h4>Conclusions</h4>Cannabis users need to be informed about the risks of developing CUDs and the higher risks among those who initiate early and use frequently during adolescence. Future studies are needed to examine how changes in cannabis policies may affect the risks of CUDs in the population.

The impediment to action advances action. — Marcus Aurelius